NLS Pharmaceutics AG (NLSP)
Oct 30, 2025 - NLSP was delisted (reason: merged into NCEL)
0.7620
+0.0220 (2.97%)
Inactive · Last trade price on Oct 30, 2025

NLS Pharmaceutics AG Statistics

Total Valuation

NLSP has a market cap or net worth of $31.64 million. The enterprise value is $91,491.

Market Cap 31.64M
Enterprise Value 91,491

Important Dates

The last earnings date was Monday, October 6, 2025, before market open.

Earnings Date Oct 6, 2025
Ex-Dividend Date n/a

Share Statistics

NLSP has 4.15 million shares outstanding. The number of shares has increased by 201.68% in one year.

Current Share Class 4.15M
Shares Outstanding 4.15M
Shares Change (YoY) +201.68%
Shares Change (QoQ) +96.52%
Owned by Insiders (%) 25.07%
Owned by Institutions (%) 8.50%
Float 2.62M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.09
P/TBV Ratio 1.12
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.77

Current Ratio 2.77
Quick Ratio 2.50
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -53.01

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -75.98%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -116.63%
Revenue Per Employee n/a
Profits Per Employee -$887,719
Employee Count 7
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -81.55% in the last 52 weeks. The beta is 0.13, so NLSP's price volatility has been lower than the market average.

Beta (5Y) 0.13
52-Week Price Change -81.55%
50-Day Moving Average 1.91
200-Day Moving Average 1.94
Relative Strength Index (RSI) 19.73
Average Volume (20 Days) 3,445,165

Short Selling Information

The latest short interest is 95,155, so 2.29% of the outstanding shares have been sold short.

Short Interest 95,155
Short Previous Month 384,862
Short % of Shares Out 2.29%
Short % of Float 3.64%
Short Ratio (days to cover) 0.12

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -3.36M
Pretax Income -2.17M
Net Income -6.21M
EBITDA -3.36M
EBIT -3.36M
Earnings Per Share (EPS) -$20.57
Full Income Statement

Balance Sheet

The company has $3.07 million in cash and n/a in debt, giving a net cash position of $3.07 million or $0.74 per share.

Cash & Cash Equivalents 3.07M
Total Debt n/a
Net Cash 3.07M
Net Cash Per Share $0.74
Equity (Book Value) 2.88M
Book Value Per Share 6.79
Working Capital 2.58M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$4.81 million and capital expenditures -$3,917, giving a free cash flow of -$4.82 million.

Operating Cash Flow -4.81M
Capital Expenditures -3,917
Free Cash Flow -4.82M
FCF Per Share -$1.16
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NLSP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -201.68%
Shareholder Yield -201.68%
Earnings Yield -196.41%
FCF Yield -152.19%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on September 27, 2024. It was a reverse split with a ratio of 1:40.

Last Split Date Sep 27, 2024
Split Type Reverse
Split Ratio 1:40

Scores

Altman Z-Score n/a
Piotroski F-Score 2